Last reviewed: May 14, 2026
Last updated: May 14, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
Yes, testosterone replacement therapy and GLP-1 medications can be used simultaneously in appropriate patients, but this requires careful provider oversight and baseline health assessment. Research indicates no direct contraindication, though metabolic interactions warrant monitoring.
Many patients explore combining TRT with GLP-1 therapy to address both hormonal optimization and metabolic health. PlexusDx supports providers in personalizing this approach through biomarker context and genetic predisposition screening before initiating dual therapy.
How TRT and GLP-1 Medications Work at the Cellular Level
Testosterone optimizes muscle protein synthesis, metabolic rate, and bone density through androgen receptor signaling. GLP-1 agonists enhance insulin sensitivity, reduce appetite via central nervous system pathways, and improve cardiovascular markers through glucagon-like peptide-1 receptor activation.
These mechanisms operate through distinct biological pathways, meaning they theoretically complement rather than compete. However, both influence glucose metabolism and insulin secretion, which means provider-guided monitoring becomes essential during concurrent use.
Clinical Evidence on Safety and Efficacy of Combined Therapy
Limited head-to-head studies directly examine TRT plus GLP-1 use in the same patient population. Available evidence comes primarily from observational reports and mechanistic studies rather than large randomized controlled trials, so provider clinical judgment remains central to decision-making.
| Treatment Factor |
Clinical Consideration |
| Insulin Sensitivity |
Both TRT and GLP-1 improve insulin signaling; combined effect may require adjusted glucose monitoring and medication dosing |
| Cardiovascular Impact |
TRT increases hemoglobin and blood viscosity; GLP-1 reduces inflammation and improves lipid profiles; net effect requires baseline cardiac assessment |
| Body Composition Changes |
TRT drives lean mass gain; GLP-1 promotes fat loss; combined effect may accelerate metabolic recomposition but needs monitoring |
| Baseline Health Status |
Patients with existing hypertension, cardiovascular disease, or metabolic syndrome require more intensive provider oversight and testing intervals |
Biomarkers Your Provider Should Monitor During Dual Therapy
Before initiating combined TRT and GLP-1 therapy, baseline labs should include lipid panels, fasting glucose or HbA1c, liver function tests, renal function, hematocrit, and testosterone or estradiol levels as applicable. Kidney function becomes particularly relevant since GLP-1 medications affect renal perfusion.
During treatment, follow-up monitoring intervals depend on individual risk factors but typically include quarterly labs for the first year, then semi-annually if stable. Hematocrit, lipids, glucose tolerance, and liver enzymes warrant closest attention in dual therapy patients.
Who Should Not Use TRT and GLP-1 Simultaneously
Patients with active or history of prostate cancer, uncontrolled hypertension above 180/110 mmHg, recent myocardial infarction or stroke, or severe kidney disease should not begin dual therapy without specialist consultation. Polycythemia or hematocrit consistently above 54% may contraindicate TRT initiation until addressed.
Medically cautious language is essential here: provider assessment of individual cardiovascular risk, family history, and current medication interactions is non-negotiable. Personalized evaluation determines eligibility, and no patient should assume dual therapy is appropriate without qualified medical oversight.
How PlexusDx Supports a More Personalized Approach
PlexusDx's Precision Peptide Genetic Test may help provide context regarding individual predispositions in GLP-1 receptor sensitivity and metabolic pathways. Key genetic variants like GLP1R rs6923761 and MC4R rs17782313 can indicate how an individual's system may respond to GLP-1 therapy, which can support more informed provider conversations during the dual-therapy evaluation.
This genetic information should be interpreted with a qualified healthcare provider and does not predict exact medication response or guarantee outcomes. Genetic predispositions are one data point among many; TRT status, existing comorbidities, and current medications carry equal or greater weight in clinical decision-making for dual therapy.
When providers have biomarker and genetic context from the Precision Peptide Genetic Test, they can better discuss individual tolerance expectations, monitoring frequency, and potential dosing adjustments for GLP-1 medications when combined with testosterone replacement.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month, or $298 standalone) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Is it safe to take testosterone and GLP-1 medication like semaglutide at the same time?
Combined use is possible in appropriately screened patients, but requires baseline labs and ongoing provider monitoring. No direct contraindication exists, though both influence glucose and cardiovascular parameters, warranting careful oversight.
What does the clinical evidence say about TRT plus GLP-1 efficacy?
Most evidence is observational rather than from large randomized trials. Mechanistically, both improve insulin sensitivity and body composition; clinical outcomes depend heavily on individual health status and adherence to provider monitoring protocols.
How can PlexusDx help evaluate whether dual therapy is right for me?
PlexusDx's Precision Peptide Genetic Test reveals genetic predispositions in GLP-1 receptor and metabolic pathways at $298 standalone or $99 as an add-on. Results support a more informed conversation with your provider about GLP-1 personalization within your dual-therapy plan.
What labs should be monitored if I'm on both TRT and a GLP-1 medication?
Baseline and ongoing monitoring should include lipids, glucose or HbA1c, liver and kidney function, hematocrit, and hormone levels. Frequency typically starts quarterly in year one, then semi-annually if stable, depending on provider assessment of your risk profile.
Can genetic testing predict how well I'll respond to GLP-1 if I'm also taking TRT?
The Precision Peptide Genetic Test reveals predispositions in peptide pathways but does not predict exact medication response or guarantee outcomes. It should be interpreted with your provider as one context-setting tool alongside your TRT status and overall health profile.
Related Reading
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
What Does Semaglutide Compound Do? Exploring the Benefits and Applications
Maximizing Your Weight Loss Journey: Can You Take Semaglutide and Sermorelin Together?